Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer

BACKGROUND: Combination therapy of irinotecan, folinic acid (FA) and 5-fluorouracil (5-FU) has been proven to be highly effective for the treatment of metastatic colorectal cancer. However, in light of safety and efficacy concerns, the best combination regimen for first-line therapy still needs to b...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Cancer
Autori principali: Teufel, Andreas, Steinmann, Silke, Siebler, Jürgen, Zanke, Christiane, Hohl, Herbert, Adami, Bernd, Schroeder, M, Klein, O, Höhler, Thomas, Galle, Peter R, Heike, Michael, Moehler, Markus
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMC 2004
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC497044/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15265233/
https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1471-2407-4-38
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi